semaglutides Tirzepatide vs. Semaglutide: What You Should Know Everything You Need to Know

Novo Nordisk plans to achieve more than 25 billion DKK ($3.72 billion) in obesity sales by 2025

Annu Navani, MD, longevity and biohacking expert and chief medical officer at Boomerang Healthcare

The drug controls appetite, delays gastric emptying and boosts metabolic function

Many patients experience the most substantial weight reductions between three and six months into their treatment

Semaglutide in the Spotlight Originally, segmaglutide, the active ingredient in popular medications such as Ozempic and Wegovy was only approved by the FDA for diabetes treatment

We remain committed to providing accurate, evidence-informed education so individuals can make well-supported decisions within a regulated medical environment